Search Team

Search by Last Name
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
 
 

Litigation

services overview
Litigation Image

Litigation

Post-Grant

Prosecution & Counseling

Our world-class trial lawyers are known for their outstanding legal skills and are in court nearly every day. We know how to present the facts and the law in ways that are clear and compelling to judges and juries, which is why we outperform other firms in high-stakes patent infringement actions. In 2018, for example, Fish won a stunning reversal of a $2.5 billion jury verdict — the largest patent damages award ever recorded in the United States — in federal court in Delaware.

Fish’s IP litigation practice dominates in every venue — U.S. District Court, the International Trade Commission (ITC), the U.S. Court of Appeals for the Federal Circuit, and the Patent Trial and Appeal Board (PTAB) — scoring more high-profile IP wins across the board than any other firm. Our success is rooted in our deep fluency in every technology area and venue imaginable, our robust industry knowledge, and our strategic and tenacious problem- solving abilities.

Fish is dedicated to an integrative, seamless, and scalable team approach. Our lawyers routinely work hand in hand with colleagues across the firm and as strategic partners with clients.
We embrace impactful innovation that drives efficiency, and we are at the forefront of creating custom, award-winning technical tools and processes that deliver value to clients. Our clients also benefit from Fish’s sophisticated Legal Project Management tools that allow us to quickly create a litigation budget, and monitor actuals in comparison with it to ensure we run cases on budget.

Representative Matters

Fish & Richardson Obtains $175 Million Settlement for Power Integrations After 15 Years of Hard-fought Litigation

October 2019 – Fish & Richardson has obtained a $175 million cash settlement for long-time client Power Integrations, Inc. in its 15-year patent litigation battle with Fairchild Semiconductor and ON Semiconductor. Read more here.

Fish & Richardson Obtains Denial of Cert at U.S. Supreme Court for Gilead Sciences in Long-Running Patent Battle with Merck Over Hepatitis C Drugs

January 2019 – Fish & Richardson has obtained a denial of certiorari at the U.S. Supreme Court for client Gilead Sciences, Inc., which keeps intact Fish’s unanimous Federal Circuit win in April 2018 that affirmed its June 2016 post-trial reversal of a $200 million jury verdict against Gilead. Read more here.


Highlights

Search Fish Litigation Team Search

What's Trending in Litigation

Filter by
Blog
March 2, 2021
EDTX & NDTX Monthly Wrap-Up – February 2021
Author: Michael Vincent
News
March 2, 2021
Fish & Richardson Secures Denial of IPR Petitions on Behalf of Moskowitz Family LLC in Spinal Surgery Patent Dispute
Press Release
Recognition
News
Event
March 31st, 2021 | 1:30 pm EDT
Webinar | Negotiation Ethics
Webinar
Event
February 23rd, 2021 | 8:00 am CET
C5 13th Annual Pharma & Biotech Patent Litigation in Europe
Speaking Engagement
Conference/Convention
News
February 5, 2021
ITC Litigation: Introduction to Trade Secret Protection at the ITC
IP Law Essentials
Blog
February 4, 2021
Biosimilars 2020 Year in Review
Authors: Kayleigh E. McGlynn, Philip K. Chen, Jenny Shmuel, Ph.D.
Event
February 24th, 2021 | 1:30 pm EST
Webinar | Protecting Your Trade Secrets from Misappropriation
Webinar
News
January 28, 2021
Fish & Richardson Wins Full Federal Circuit Reversal and Summary Judgment of Non-Infringement for uCloudlink in Patent Dispute
Press Release
News
News
January 26, 2021
Kurt Glitzenstein Quoted in The American Lawyer "Litigation Leaders" Article
Media Mention
News
Blog
January 26, 2021
EDTX & NDTX Monthly Wrap-Up – December 2020
Author: Michael Ellis
News
January 25, 2021
Fish & Richardson Named #1 PTAB Law Firm of 2020 by Managing Intellectual Property
Press Release
Recognition
News
Blog
January 19, 2021
Recent Developments in Trade Secrets Damages
Authors: Esha Bandyopadhyay, Tommy Jacks
load more topics